Diabetic Polyneuropathy and Associated Factors in a Population of Type 2 Diabetic Patients in Garoua, Cameroon
- 1 Garoua General Hospital, Garoua, Cameroun
- 2 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 3 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 4 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 5 Garoua Regional Hospital, Garoua, Cameroun
- 6 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 7 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 8 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 9 Department of Medicine and Traditional Pharmacopeia, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 10 Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
- 11 Garoua General Hospital, Garoua, Cameroun
- 12 Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroun
- 13 Department of Physiological Sciences and Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroun
Abstract
Introduction: Diabetic polyneuropathy (DPN) is the most common complication of diabetes, affecting nearly half of patients with type 2 diabetes. The aim of this study was to determine the prevalence and factors associated to DPN. Methods: We conducted a cross-sectional study from January to May 2024 at the Garoua Regional Hospital (GRH) and the Garoua General Hospital (HGG), involving type 2 diabetic patients. The DN-4 questionnaire, a screening tool for diabetic polyneuropathy comprising 10 items, was used as a diagnostic tool. The diagnosis was established based on a score ≥ 4. A logistic regression model was used to identify factors associated to DPN. The significance level was set at 5%. Results: Among the 203 patients included in the study, with a median (IQR) age of 56 (48 - 63) years, 68.5% were female. The median (IQR) duration of diabetes was 5 (2 - 9) years, with a median (IQR) glycated hemoglobin level of 8.80% (7.50% - 10.6%). Dyslipidemia was the most common additional cardiovascular risk factor (65.35%). The prevalence (95% CI) of painful diabetic neuropathy was 45.81% (38.82% - 52.96%). The main associated factors [aOR (95% CI), p] were female sex [3.65 (1.62 - 8.23), p = 0.037], age ≥ 60 years [4.57, (2.11 - 9.86), (p = 0.048)], diabetes duration ≥ 10 years [2.93. (1.16 - 7.45), (p = 0.006)], glycated hemoglobin level ≥ 7% [3.99, (1.25 - 5.72), (p = 0.043)] and chronic kidney disease [4.79, (2.22 - 7.54), (p = 0.009)]. Conclusion: The high prevalence of diabetic polyneuropathy and its multiple associated factors highlight a major challenge in its prevention, particularly through optimal glycaemic control, in order to improve patients’ quality of life.
- Magliano, D.J., Boyko, E.J. and IDF Diabetes Atlas 10th Edition Scientific Committee (2021) IDF Diabetes Atlas. 10th Edition, International Diabetes Federation. http://www.ncbi.nlm.nih.gov/books/NBK581934/
- Glovaci, D., Fan, W. and Wong, N.D. (2019) Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Current Cardiology Reports , 21, 21. https://doi.org/10.1007/s11886-019-1107-y
- Lutte contre le diabète au Cameroun Riposte collective contre le tueur silencieux| MINSANTE. https://www.minsante.cm/site/?q=fr/content/lutte-contre-le-diab%C3%A8te-au-cameroun-riposte-collective-contre-le-tueur-silencieux
- Elleuch, M., Hssine, H., Affes, L., Salah, B., Boujelbene, K.H., Khlif, R., et al . (2023) Prévalence et facteurs prédictifs de la polyneuropathie distale et symétrique diabétique. JI MSfax , 44, 38-42. https://www.medecinesfax.org/useruploads/files/Article6-44.pdf
- Davies, M., Brophy, S., Williams, R. and Taylor, A. (2006) The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. Diabetes Care , 29, 1518-1522. https://doi.org/10.2337/dc05-2228
- Owolabi, L.F., Alghamdi, M., Adamu, B., Taura, M.G., Jibo, A., Almansour, M., et al . (2022) Magnitude of Diabetic Peripheral Neuropathy in Saudi Arabia: A Systematic Review and Meta-Analysis. BMC Endocrine Disorders , 22, Article No. 266. https://doi.org/10.1186/s12902-022-01167-4
- Dumont, I. (2011) Painful Diabetic Neuropathy: Diagnosis and Management. Diabetes & Metabolism. https://www.academia.edu/22790870/Painful_diabetic_neuropathy_Diagnosis_and_management
- Aynaou, H. and Latrech, H. (2019) Neuropathie Diabétique Périphérique Au CHU Mohamed VI d’Oujda. IOSR-JDMS , 18, 64-68. https://www.iosrjournals.org/iosr-jdms/papers/Vol18-issue8/Series-5/M1808056468.pdf
- Chahbi, Z., Lahmar, B., El Hadri, S., Abainou, L., Kaddouri, S., Qacif, H., et al . (2018) The Prevalence of Painful Diabetic Neuropathy in 300 Moroccan Diabetics. Pan African Medical Journal , 31, Article No. 158. https://doi.org/10.11604/pamj.2018.31.158.14687
- Simo, N., Kuate-Tegueu, C., Ngankou-Tchankeu, S., Doumbe, J., Maiga, Y., Cesari, M., et al . (2020) Correlates of Diabetic Polyneuropathy of the Elderly in Sub-Saharan Africa. PLOS ONE , 15, e0240602. https://doi.org/10.1371/journal.pone.0240602
- Dehayem Yefou, M., Sobngwi, E., Nwatsock, J.F., Maka Mani, J., Jupkwo, B. and Mbanya, J.C. (2010) P86 Prise en charge du diabète sucré au Cameroun: Résultats de l’étude Diabcare. Diabetes & Metabolism , 36, A59-A60. https://doi.org/10.1016/s1262-3636(10)70234-2